Kite, a Gilead Company, has presented new findings demonstrating the safety, efficacy and quality of life benefits offered by ...

Pfizer has announced results from its phase 3 BASIS study of Hympavzi (marstacimab), demonstrating its success in reducing ...

Embodiment Perhaps more philosophical, but none-the less highly relevant, is the concept of embodiment – the experience of ...

Our 2025 EcoVadis reassessment has resulted in a score of 75/100, allowing us to maintain our silver medal status for the 3rd year running. This achievement places us in the top 15% of all companies ...

As global pricing reforms squeeze margins and reshapes supply chains, manufacturers can restore confidence through smarter ...

NRG Therapeutics has appointed Paul Thompson as its new Chief Development Officer, who brings specialist expertise in ...

New results from the phase 1 VNA-318-01 human study have shown favourable safety and tolerability, with the data showing that ...

AI-generated personas can assist in brainstorming with a hypothetical HCP, validate test queries for medical information ...

Some bad decisions are the result of biases, of which there are various flavours, such as confirmation, anchoring and recency ...

Roche has received clearance from the US Food and Drug Administration (FDA) for its point of care diagnostic test for ...

TRIMTECH Therapeutics has appointed Alison Lawton as the new Chair of its Board of Directors.

We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to solve marketing challenges and drive sustainable change, ...